Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer

Background: Aberrant Wnt signalling, regulating cell development and stemness, influences the development of many cancer types. The Aryl hydrocarbon receptor (AhR) mediates tumorigenesis of environmental pollutants. Complex interaction patterns of genes assigned to AhR/Wnt-signalling were recently a...

Full description

Bibliographic Details
Main Authors: Albanes, D. (Author), Aldrich, M.C (Author), Amos, C.I (Author), Andrew, A.S (Author), Arnold, S.M (Author), Bickeböller, H. (Author), Bojesen, S.E (Author), Brennan, P. (Author), Caporaso, N.E (Author), Chen, C. (Author), Christiani, D.C (Author), Cox, A. (Author), Davies, M.P.A (Author), Doherty, J.A (Author), Duell, E.J (Author), Fernández-Tardón, G. (Author), Field, J.K (Author), Goodman, G.E (Author), Haugen, A. (Author), Hung, R.J (Author), Johansson, M. (Author), Kiemeney, L.A (Author), Lam, S. (Author), Landi, M.T (Author), Lazarus, P. (Author), Le Marchand, L. (Author), Liloglou, T. (Author), Liu, G. (Author), Muley, T.R (Author), Muttray, N. (Author), Rennert, G. (Author), Risch, A. (Author), Rosenberger, A. (Author), Schabath, M.B (Author), Shete, S.S (Author), Tardon, A. (Author), Taylor, F. (Author), The INTEGRAL-ILCCO Consortium (Author), Wendel, B. (Author), Woll, P.J (Author), Zienolddiny, S. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 05343nam a2201117Ia 4500
001 10-1186-s40001-022-00638-7
008 220420s2022 CNT 000 0 und d
020 |a 09492321 (ISSN) 
245 1 0 |a Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer 
260 0 |b BioMed Central Ltd  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1186/s40001-022-00638-7 
520 3 |a Background: Aberrant Wnt signalling, regulating cell development and stemness, influences the development of many cancer types. The Aryl hydrocarbon receptor (AhR) mediates tumorigenesis of environmental pollutants. Complex interaction patterns of genes assigned to AhR/Wnt-signalling were recently associated with lung cancer susceptibility. Aim: To assess the association and predictive ability of AhR/Wnt-genes with lung cancer in cases and controls of European descent. Methods: Odds ratios (OR) were estimated for genomic variants assigned to the Wnt agonist and the antagonistic genes DKK2, DKK3, DKK4, FRZB, SFRP4 and Axin2. Logistic regression models with variable selection were trained, validated and tested to predict lung cancer, at which other previously identified SNPs that have been robustly associated with lung cancer risk could also enter the model. Furthermore, decision trees were created to investigate variant × variant interaction. All analyses were performed for overall lung cancer and for subgroups. Results: No genome-wide significant association of AhR/Wnt-genes with overall lung cancer was observed, but within the subgroups of ever smokers (e.g., maker rs2722278 SFRP4; OR = 1.20; 95% CI 1.13–1.27; p = 5.6 × 10–10) and never smokers (e.g., maker rs1133683 Axin2; OR = 1.27; 95% CI 1.19–1.35; p = 1.0 × 10–12). Although predictability is poor, AhR/Wnt-variants are unexpectedly overrepresented in optimized prediction scores for overall lung cancer and for small cell lung cancer. Remarkably, the score for never-smokers contained solely two AhR/Wnt-variants. The optimal decision tree for never smokers consists of 7 AhR/Wnt-variants and only two lung cancer variants. Conclusions: The role of variants belonging to Wnt/AhR-pathways in lung cancer susceptibility may be underrated in main-effects association analysis. Complex interaction patterns in individuals of European descent have moderate predictive capacity for lung cancer or subgroups thereof, especially in never smokers. © 2022, The Author(s). 
650 0 4 |a adult 
650 0 4 |a AhR gene 
650 0 4 |a aromatic hydrocarbon receptor 
650 0 4 |a Article 
650 0 4 |a Association 
650 0 4 |a Axin2 gene 
650 0 4 |a cancer risk 
650 0 4 |a cancer susceptibility 
650 0 4 |a controlled study 
650 0 4 |a decision tree 
650 0 4 |a Decision trees 
650 0 4 |a DKK2 gene 
650 0 4 |a DKK3 gene 
650 0 4 |a DKK4 gene 
650 0 4 |a European 
650 0 4 |a female 
650 0 4 |a FRZB gene 
650 0 4 |a gene 
650 0 4 |a gene interaction 
650 0 4 |a Gene–gene integration 
650 0 4 |a genetic variability 
650 0 4 |a genome-wide association study 
650 0 4 |a human 
650 0 4 |a human tissue 
650 0 4 |a lung cancer 
650 0 4 |a major clinical study 
650 0 4 |a male 
650 0 4 |a middle aged 
650 0 4 |a never smoker 
650 0 4 |a Never smoker 
650 0 4 |a Polygenic risk score 
650 0 4 |a Prediction 
650 0 4 |a predictive value 
650 0 4 |a secreted frizzled related protein 4 
650 0 4 |a SFRP4 gene 
650 0 4 |a single nucleotide polymorphism 
650 0 4 |a small cell lung cancer 
650 0 4 |a Small cell lung cancer 
650 0 4 |a smoking 
650 0 4 |a Susceptibility 
650 0 4 |a Wnt gene 
650 0 4 |a Wnt protein 
700 1 0 |a Albanes, D.  |e author 
700 1 0 |a Aldrich, M.C.  |e author 
700 1 0 |a Amos, C.I.  |e author 
700 1 0 |a Andrew, A.S.  |e author 
700 1 0 |a Arnold, S.M.  |e author 
700 1 0 |a Bickeböller, H.  |e author 
700 1 0 |a Bojesen, S.E.  |e author 
700 1 0 |a Brennan, P.  |e author 
700 1 0 |a Caporaso, N.E.  |e author 
700 1 0 |a Chen, C.  |e author 
700 1 0 |a Christiani, D.C.  |e author 
700 1 0 |a Cox, A.  |e author 
700 1 0 |a Davies, M.P.A.  |e author 
700 1 0 |a Doherty, J.A.  |e author 
700 1 0 |a Duell, E.J.  |e author 
700 1 0 |a Fernández-Tardón, G.  |e author 
700 1 0 |a Field, J.K.  |e author 
700 1 0 |a Goodman, G.E.  |e author 
700 1 0 |a Haugen, A.  |e author 
700 1 0 |a Hung, R.J.  |e author 
700 1 0 |a Johansson, M.  |e author 
700 1 0 |a Kiemeney, L.A.  |e author 
700 1 0 |a Lam, S.  |e author 
700 1 0 |a Landi, M.T.  |e author 
700 1 0 |a Lazarus, P.  |e author 
700 1 0 |a Le Marchand, L.  |e author 
700 1 0 |a Liloglou, T.  |e author 
700 1 0 |a Liu, G.  |e author 
700 1 0 |a Muley, T.R.  |e author 
700 1 0 |a Muttray, N.  |e author 
700 1 0 |a Rennert, G.  |e author 
700 1 0 |a Risch, A.  |e author 
700 1 0 |a Rosenberger, A.  |e author 
700 1 0 |a Schabath, M.B.  |e author 
700 1 0 |a Shete, S.S.  |e author 
700 1 0 |a Tardon, A.  |e author 
700 1 0 |a Taylor, F.  |e author 
700 1 0 |a The INTEGRAL-ILCCO Consortium  |e author 
700 1 0 |a Wendel, B.  |e author 
700 1 0 |a Woll, P.J.  |e author 
700 1 0 |a Zienolddiny, S.  |e author 
773 |t European Journal of Medical Research